Targets of the Tumor Suppressor <i>miR-200</i> in Regulation of the Epithelial–Mesenchymal Transition in Cancer
Mark J. Schliekelman(Fred Hutch Cancer Center), Samir Hanash(The University of Texas MD Anderson Cancer Center), Christin Ungewiss(Fred Hutch Cancer Center), Vítor M. Faça(Universidade de Ribeirão Preto), Chad J. Creighton(Baylor College of Medicine), Chee‐Hong Wong(The University of Texas MD Anderson Cancer Center), Dong Hoon Shin(National Cancer Center), Qing Zhang(Southwestern Medical Center), Hong Wang(The University of Texas MD Anderson Cancer Center), Jonathan M. Kurie(The University of Texas MD Anderson Cancer Center), Young‐Ho Ahn(Ewha Womans University), Zain H. Rizvi(The University of Texas MD Anderson Cancer Center), Don L. Gibbons(The University of Texas MD Anderson Cancer Center)
Cited by 138
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k